| PACKAGING TYPE: | 1x60 C-box |
| COMPOSITION: | Sorafenib 200mg |
| FORMULATION: | Tablets |
| Description: | SOFENIB-200 Tablet contains Sorafenib 200mg, an oral multi-kinase inhibitor used in the treatment of certain types of cancer, including hepatocellular carcinoma (liver cancer), renal cell carcinoma (kidney cancer), and differentiated thyroid carcinoma. It works by inhibiting tumor cell proliferation and blocking angiogenesis (blood supply to tumors), thereby slowing cancer growth and progression. This targeted therapy plays a crucial role in advanced-stage cancer management. |
| Side Effects: | Common side effects may include: Fatigue Diarrhea Hand-foot skin reaction (palmar-plantar erythrodysesthesia) Rash Hypertension Serious (rare) side effects: Severe bleeding Cardiac issues Liver dysfunction Gastrointestinal perforation Severe skin reactions |
| How to Use: | Take the tablet exactly as prescribed by your oncologist Usually taken twice daily on an empty stomach Swallow whole with water; do not crush or chew Take at least 1 hour before or 2 hours after meals Follow strict medical supervision during therapy |
| Precaution: | Use only under oncologist supervision Regular monitoring of liver function and blood pressure is required Avoid during pregnancy and breastfeeding Use effective contraception during treatment Inform doctor about heart disease or bleeding disorders Avoid grapefruit products during therapy Dose adjustment may be required based on tolerance |
| Product Benefits: | Effective targeted therapy for liver, kidney, and thyroid cancers Inhibits tumor growth and spread Blocks tumor blood vessel formation (anti-angiogenic effect) Helps improve progression-free survival Oral administration for patient convenience Suitab |
Frequently Asked Questions
It is used to treat liver cancer, kidney cancer, and thyroid cancer.
No, it is a targeted therapy (multi-kinase inhibitor), not traditional chemotherapy.
It helps control and slow the progression of cancer but may not cure it completely.










